Profil bibliographique

Khouloud Kouidri

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées

72Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Acute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell TransplantationLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Publications récentes

Accès ouvert 2026 articleOpenAlex

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world study

Desireé Kunadt, Sven Zukunft, Christoph Röllig, S K Metzelder et autres

0 citationsBritish Journal of Haematology

Accès ouvert 2025 conference-abstractOpenAlex

CDK7 enables adaptive gene transcription required by stromal cells to support distinct T-cell lymphoma phenotypes and represents a novel microenvironment-directed therapeutic target

Khouloud Kouidri, Danilo Fiore, María V. Revuelta, Nicolás Di Siervi et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Efficacy and safety of vipor (P) in relapsed or refractory large B-cell lymphoma

Thomas Oellerich, Rebecca Wurm‐Kuczera, Shashwat Sahay, Meng Wang et autres

1 citationBlood

Accès ouvert 2025 conference-abstractOpenAlex

Primary central nervous system lymphoma reveals a pro-tumoral brain-specific myeloid landscape.

María V. Revuelta, Nahuel Zamponi, Khouloud Kouidri, Federico Ruiz Moreno et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

118 | CDK7 ENABLES THE FUNCTIONAL CROSSTALK BETWEEN LYMPHOMA AND MICROENVIRONMENT (TME) CELLS IN PERIPHERAL T‐CELL LYMPHOMA (PTCL)

Khouloud Kouidri, Danilo Fiore, María V. Revuelta, Nicolás Di Siervi et autres

0 citationsHematological Oncology

Accès ouvert 2024 articleOpenAlex

Central nervous system relapse after allogeneic HCT in FLT3-mutated AML

Khouloud Kouidri, Fabian Acker, Rosa Toenges, Saskia Pfaff et autres

2 citationsAnnals of Hematology

Accès ouvert 2024 conference-abstractOpenAlex

Real-World Evidence of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Lenalidomide with or without Polatuzumab (VIPOR(P)) for Relapsed/Refractory Large B-Cell Lymphoma

Rebecca Wurm‐Kuczera, Khouloud Kouidri, Meng Wang, Shashwat Sahay et autres

2 citationsBlood

Accès ouvert 2024 preprintOpenAlex

Central nervous system relapse after allogeneic HCT in FLT3-mutated AML

Khouloud Kouidri, Fabian Acker, Rosa Toenges, Saskia Pfaff et autres

0 citationsResearch Square

2024 articleOpenAlex

Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration

Rosa Toenges, Fabian Lang, Rakhshinda Ghaffar, Sarah Lindner et autres

4 citationsAnnals of Hematology

Accès ouvert 2024 articleOpenAlex

Real‐world effectiveness of first‐line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy

Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf et autres

11 citationsEuropean Journal Of Haematology

Accès ouvert 2024 preprintOpenAlex

Real-World Effectiveness of First-Line Azacitidine or Decitabine with or without Venetoclax in AML Patients Unfit for Intensive Therapy

Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf et autres

0 citationsResearch Square

Accès ouvert 2023 articleOpenAlex

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML

Anjali Cremer, Julius C. Enßle, Saskia Pfaff, Khouloud Kouidri et autres

5 citationsAnnals of Hematology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.